ArticleOphthalmology science2023
Deep-Learning-Aided Diagnosis of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma Based on Structural and Angiographic OCT.
Article in Ophthalmology science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.
- Vitreoretinal disease detection using artificial intelligence: a systematic review and meta-analysis.International ophthalmology · 2026Pooled it
- Artificial intelligence in glaucoma: opportunities, challenges, and future directions.Biomedical engineering online · 2023Pooled it
- Automated Assessment of OCT Angiography Image Quality Using the Artificial Intelligence Ready and Exploratory Atlas for Diabetes Insights Data Set.Ophthalmology science · 2026Article
- Leading Towards a Translation Readiness Framework: A Systematic Review of Deep Learning Approaches for Eye Disease Diagnosis.Diagnostics (Basel, Switzerland) · 2026Review
- Applicability study of AI attribution methods for ophthalmic image classification.Scientific reports · 2026Article
- A two-stage deep learning framework with progressive feature fusion and attention mechanisms for multi-class retinal disease classification.Frontiers in artificial intelligence · 2026Article
- Association of Physical Frailty and Genetic Predisposition with Risk of Irreversible Eye Diseases.Ophthalmology science · 2026Article
- Artificial intelligence-driven diagnosis for age-related macular degeneration bridging pathology and engineering: a survey.International ophthalmology · 2025Review
- AI-aided segmentation of four types of drusen in volumetric OCT.Biomedical optics express · 2025Article
- Novel Deep Learning Model for Glaucoma Detection Using Fusion of Fundus and Optical Coherence Tomography Images.Sensors (Basel, Switzerland) · 2025Article
- Widefield OCT angiography.Progress in retinal and eye research · 2025Review
- Advancing Diabetic Retinopathy Screening: A Systematic Review of Artificial Intelligence and Optical Coherence Tomography Angiography Innovations.Diagnostics (Basel, Switzerland) · 2025Review
- Advances in OCT Angiography.Translational vision science & technology · 2025Review
- A Deep Learning Network for Accurate Retinal Multidisease Diagnosis Using Multiview Fusion of En Face and B-Scan Images: A Multicenter Study.Translational vision science & technology · 2024Article
- Recent advances in the application of artificial intelligence in age-related macular degeneration.BMJ open ophthalmology · 2024Review
- Associations of human blood metabolome with optic neurodegenerative diseases: a bi-directionally systematic mendelian randomization study.Lipids in health and disease · 2024Article
- AI-based 3D analysis of retinal vasculature associated with retinal diseases using OCT angiography.Biomedical optics express · 2024Article
- Advancing Ocular Imaging: A Hybrid Attention Mechanism-Based U-Net Model for Precise Segmentation of Sub-Retinal Layers in OCT Images.Bioengineering (Basel, Switzerland) · 2024Article
- Deep-Ocular: Improved Transfer Learning Architecture Using Self-Attention and Dense Layers for Recognition of Ocular Diseases.Diagnostics (Basel, Switzerland) · 2023Article
- OCT angiography and its retinal biomarkers [Invited].Biomedical optics express · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Timely diagnosis of eye diseases is paramount to obtaining the best treatment outcomes. OCT and OCT angiography (OCTA) have several advantages that lend themselves to early detection of ocular pathology; furthermore, the techniques produce large, feature-rich data volumes. However, the full clinical potential of both OCT and OCTA is stymied when complex data acquired using the techniques must be manually processed. Here, we propose an automated diagnostic framework based on structural OCT and OCTA data volumes that could substantially support the clinical application of these technologies. Design: Cross sectional study. Participants: Five hundred twenty-six OCT and OCTA volumes were scanned from the eyes of 91 healthy participants, 161 patients with diabetic retinopathy (DR), 95 patients with age-related macular degeneration (AMD), and 108 patients with glaucoma. Methods: The diagnosis framework was constructed based on semisequential 3-dimensional (3D) convolutional neural networks. The trained framework classifies combined structural OCT and OCTA scans as normal, DR, AMD, or glaucoma. Fivefold cross-validation was performed, with 60% of the data reserved for training, 20% for validation, and 20% for testing. The training, validation, and test data sets were independent, with no shared patients. For scans diagnosed as DR, AMD, or glaucoma, 3D class activation maps were generated to highlight subregions that were considered important by the framework for automated diagnosis. Main Outcome Measures: The area under the curve (AUC) of the receiver operating characteristic curve and quadratic-weighted kappa were used to quantify the diagnostic performance of the framework. Results: For the diagnosis of DR, the framework achieved an AUC of 0.95 ± 0.01. For the diagnosis of AMD, the framework achieved an AUC of 0.98 ± 0.01. For the diagnosis of glaucoma, the framework achieved an AUC of 0.91 ± 0.02. Conclusions: Deep learning frameworks can provide reliable, sensitive, interpretable, and fully automated diagnosis of eye diseases. Financial Disclosures: Proprietary or commercial disclosure may be found after the references.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.